Embryonic stem cells offer new treatment for multiple sclerosis
Monday, June 16, 2014 - 17:40
in Biology & Nature
A novel approach to treating multiple sclerosis using human embryonic stem cells appears to offer better treatment results than stem cells derived from human adult bone marrow, scientists say. An advantage of human embryonic stem cells is that they can be propagated indefinitely in lab cultures and provide an unlimited source of high quality mesenchymal stem cells -- the kind of stem cell needed for treatment of MS.